News

Cambridge, MA, USA and Krakow, Poland, November 7, 2014 / B3C newswire / -Felicitex Therapeutics, a leader in the diagnostics and development of therapeutics for quiescent cancers, and Selvita (PL: SLV), the largest drug discovery company in Central and...

Munich, Germany, November 7, 2014 / B3C newswire / - Horst Lindhofer, CEO of LINDIS Biotech and inventor of the trifunctional antibody technology succeeded in regaining the relevant IP and know-how from TRION Pharma out of the insolvency proceedings....

Bristol-Myers Squibb (BMS) has expanded its existing biologics manufacturing agreement with Switzerland-based Lonza. The contract is expanded for the production of commercial quantities of a second BMS biologic medicine at Lonza's mammalian manufacturing facility...

ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has obtained approval in Canada, for its Triumeq (dolutegravir) 50mg, abacavir 600mg, and lamivudine 300mg) to treat patients with Human Immunodeficiency Virus (HIV-1) infection. ...

The World Health Organisation (WHO) has warned West Africa may face up to 10,000 new Ebola cases per week within two months, due to the increasing number of patients. With a reported death rate...

The women – all current or former employees – are seeking $250 million in damages for claims that the drug maker allowed discriminatory and disparate pay and promotion policies and had a hostile work environment – referred to as...

British drug maker GlaxoSmithKline (GSK) has signed an agreement with Aspen Global (AGI) to acquire interest in its newly established subsidiary Aspen Japan. As part of the deal, GSK will acquire a 25%...